We would love to hear your thoughts about our site and services, please take our survey here.
Not sure how you think this is the boards fault ?
"Its a mess, its a crock up, it was always avoidable. Start being truthful for once in this utter farce"
I think you need to listen to your own "OPINION"
The board have steered this company to the best of their ability as far as I’m concerned.
What's it got to do with you? YOU ARE NOT A SHARE HOLDER !
The board are dealing with the situation in hand. You are not an investor. Please leave.
I would say so. Its nearly priced to fail to be honest.
Someone with a lot of money is loading up :)
Can it stop please ? You guys havent got a clue what your talking about.
Hi Andy
The company is currently trading well. They are restricting some avenues of revenue to create a strong balance sheet. All major fee wins will be directed to paying down debt as it currently stands.
The company is trading well undervalue in my opinion and should be over a £1 at a minimum. I would suggest reviewing some of the investor presentations as they are quite self-explanatory. Personally I have high hopes for this companies future, and hope that patience will be rewarded in 5 to 10 years’ time. But I do feel you may have got into the stock at the right time.
Good luck.
Your attitude and comments are pathetic. Pot kettle black ?
How can you access WH Ireland report if you don’t mind me asking ?
Significantly undervalued now.
Why ?
I know what you mean but thy have significant cash at the moment.
It doesnt matter
Tend to agree. But true value will come in the end. The only thing that bugs me slightly is that the growth rate isn’t great. At this level (current revenues) they should be targeting between 35-50% growth levels year on year if the market is that scalable. They really need to start pumping up the distribution agreements to drive the company forward and trigger the expansion plans asap. I believe 2023 results and the next year is crucial for a turn in sentiment for Tissue Regenix.
For some reason, the company doesn’t seem to appeal to investors. The daily volumes are terribly poor, and this is something the company and nominated brokers need to review and sort out.
It’s amazing how many healthcare companies are valued over 500 million on alternative markets and have been losing tens of millions year on year, and our company is becoming profitable and is valued at a poxy 37 million at the current share price.
Are you Russian by any chance?
There is only one muppet im affraid.
Poly K will be back on LSE in two years. Patience will prevail. A clever board maneuvering around a tornado.
Please stop with the ridiculous comments